15-44663584-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_025137.4(SPG11):​c.64A>G​(p.Met22Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000646 in 1,596,660 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M22T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0033 ( 6 hom., cov: 32)
Exomes 𝑓: 0.00036 ( 3 hom. )

Consequence

SPG11
NM_025137.4 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.02

Publications

3 publications found
Variant links:
Genes affected
SPG11 (HGNC:11226): (SPG11 vesicle trafficking associated, spatacsin) The protein encoded by this gene is a potential transmembrane protein that is phosphorylated upon DNA damage. Defects in this gene are a cause of spastic paraplegia type 11 (SPG11). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]
SPG11 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 11
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Illumina, G2P
  • amyotrophic lateral sclerosis type 5
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Charcot-Marie-Tooth disease axonal type 2X
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • juvenile amyotrophic lateral sclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004727304).
BP6
Variant 15-44663584-T-C is Benign according to our data. Variant chr15-44663584-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 316118.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00331 (505/152344) while in subpopulation AFR AF = 0.0118 (490/41582). AF 95% confidence interval is 0.0109. There are 6 homozygotes in GnomAd4. There are 240 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPG11NM_025137.4 linkc.64A>G p.Met22Val missense_variant Exon 1 of 40 ENST00000261866.12 NP_079413.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPG11ENST00000261866.12 linkc.64A>G p.Met22Val missense_variant Exon 1 of 40 1 NM_025137.4 ENSP00000261866.7 Q96JI7-1

Frequencies

GnomAD3 genomes
AF:
0.00328
AC:
500
AN:
152226
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0117
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000850
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000590
AC:
124
AN:
210126
AF XY:
0.000412
show subpopulations
Gnomad AFR exome
AF:
0.00954
Gnomad AMR exome
AF:
0.000311
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000182
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000188
GnomAD4 exome
AF:
0.000364
AC:
526
AN:
1444316
Hom.:
3
Cov.:
32
AF XY:
0.000313
AC XY:
225
AN XY:
717706
show subpopulations
African (AFR)
AF:
0.0134
AC:
445
AN:
33300
American (AMR)
AF:
0.000486
AC:
21
AN:
43210
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25694
East Asian (EAS)
AF:
0.000127
AC:
5
AN:
39260
South Asian (SAS)
AF:
0.0000828
AC:
7
AN:
84550
European-Finnish (FIN)
AF:
0.0000215
AC:
1
AN:
46444
Middle Eastern (MID)
AF:
0.000348
AC:
2
AN:
5742
European-Non Finnish (NFE)
AF:
0.00000181
AC:
2
AN:
1106352
Other (OTH)
AF:
0.000719
AC:
43
AN:
59764
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
34
69
103
138
172
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00331
AC:
505
AN:
152344
Hom.:
6
Cov.:
32
AF XY:
0.00322
AC XY:
240
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.0118
AC:
490
AN:
41582
American (AMR)
AF:
0.000784
AC:
12
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68022
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
25
49
74
98
123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000407
Hom.:
1
Bravo
AF:
0.00357
ESP6500AA
AF:
0.00813
AC:
34
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000722
AC:
86
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SPG11: BS1 -

Feb 19, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32166880) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hereditary spastic paraplegia 11 Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

-
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Benign:1
Dec 12, 2016
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Amyotrophic lateral sclerosis type 5 Benign:1
-
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease axonal type 2X Benign:1
-
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
8.8
DANN
Benign
0.61
DEOGEN2
Benign
0.010
T;.;T;.;.
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.60
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.57
T;T;T;T;T
MetaRNN
Benign
0.0047
T;T;T;T;T
MetaSVM
Benign
-0.67
T
MutationAssessor
Uncertain
2.0
M;M;.;M;.
PhyloP100
1.0
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-0.93
N;N;N;N;N
REVEL
Benign
0.16
Sift
Benign
0.047
D;D;D;T;D
Sift4G
Uncertain
0.050
T;D;T;D;D
Polyphen
0.0
B;.;B;.;.
Vest4
0.23
MVP
0.58
MPC
0.037
ClinPred
0.032
T
GERP RS
4.6
PromoterAI
-0.11
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.41
gMVP
0.48
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34255962; hg19: chr15-44955782; API